Livagen (20mg Khavinson Bioregulator)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: Livagen is a synthetic Khavinson tetrapeptide (Lys-Glu-Asp-Ala) specifically targeted at hepatic parenchyma. It stimulates nuclear chromatin decondensation and reactivates protein synthesis in aged hepatocyte cultures.
How it works: KEDA acts as an epigenetic modifier that loosens heterochromatin condensation around nucleolar organizer regions (NORs), reactivating ribosomal RNA (rRNA) gene transcription. In hepatocyte cell challenge models, it stabilizes microsomal cytochrome P450 baseline expression, accelerates regeneration kinetics, and normalizes cellular transaminase release.
Why researchers study it: Evaluated in studies of cellular aging, nucleolar chromatin reactivation, hepatocyte metabolic resilience under toxicological challenge, and protein synthesis recovery in senescent hepatic tissue.
